BridgeBio Pharma, Inc. (BBIO)

76.49 +1.01 (+1.34%) USD  |  NASDAQ  |  Dec 31, 16:00
77.15 +0.66 (+0.86%) After-Hours: 20:00
More

BridgeBio Pharma EPS LT Growth Estimates

EPS LT Growth Estimates Chart

View EPS LT Growth Estimates for BBIO.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View EPS LT Growth Estimates Chart
Start Trial

Historical Data

View Historical Data
Start Trial

EPS LT Growth Estimates Range, Past 5 Years

View EPS LT Growth Estimates Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

EPS LT Growth Estimates Benchmarks

View EPS LT Growth Estimates Benchmarks
Start Trial
Pfizer Inc. Upgrade
Alnylam Pharmaceuticals, Inc. --
Supernus Pharmaceuticals, Inc. Upgrade
Ionis Pharmaceuticals, Inc. Upgrade
Regeneron Pharmaceuticals, Inc. Upgrade